Formulation and Evaluation of Extended Release Asymmetric Membrane Capsules of Atenolol

被引:4
作者
Guarve, Kumar [1 ]
Gupta, G. D. [2 ]
机构
[1] Guru Gobind Singh Coll Pharm, Yamunanagar, Haryana, India
[2] ASBASJSM Coll Pharm, Bela, Punjab, India
关键词
Extended release; asymmetric capsule; atenolol; pH regulating; citric acid; PH-INDEPENDENT RELEASE; OSMOTIC DRUG-DELIVERY; HPMC MATRIX TABLETS; WEAKLY BASIC DRUGS; HYDROPHILIC MATRICES; CITRIC-ACID; PROFILE;
D O I
10.2174/156720111794479899
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to demonstrate that the asymmetric membrane capsule can be used to deliver a poorly water soluble drug with a pH dependent solubility such as atenolol for extended periods of time by modulating solubility with organic acid. In osmotic systems, the release rate of an excipient relative to the release rate of the drug is an important factor that determines the duration of drug release. Consequently, for maintaining the desired pH over the entire period of drug dissolution a suitable thickening and suspending agent can be incorporated. By optimizing the concentration of thickening agent, it is possible to extend the availability of pH modifier in the core to provide an osmotic driving force or solubilization over the entire delivery period, so that the desired profile can be achieved for an active agent that has lower solubility characteristics. Finally, it was observed that the release rate of atenolol was influenced by the concentration of citric acid, mannitol and hydroxypropyl methylcellulose (HPMC). Results of scanning electron microscopy studies showed the formation of pores in the membrane from where the drug release occurred. The optimal formulation was found to be able to deliver atenolol at the rate of approximate zero-order up to 24 h, independent of pH of release media and agitation rate.
引用
收藏
页码:159 / 163
页数:5
相关论文
共 19 条
  • [1] [Anonymous], [No title captured], Patent No. [4,968,507, 4968507]
  • [2] AYER A, 1988, Patent No. 4732915
  • [3] Influence of admired citric acid on the release profile of pelanserin hydrochloride from HPMC matrix tablets
    Espinoza, R
    Hong, E
    Villafuerte, L
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 201 (02) : 165 - 173
  • [4] GABR KE, 1992, EUR J PHARM BIOPHARM, V38, P199
  • [5] GENNARO AR, 1990, REMINGTON SCI PRACTI, P900
  • [6] The effect of citric acid added to hydroxypropyl methylcellulose (HPMC) matrix tablets on the release of profile of vinpocetine
    Nie, SF
    Pan, WS
    Li, XD
    Wu, XM
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2004, 30 (06) : 627 - 635
  • [7] OSMOTIC DRUG-DELIVERY - A REVIEW OF THE PATENT LITERATURE
    SANTUS, G
    BAKER, RW
    [J]. JOURNAL OF CONTROLLED RELEASE, 1995, 35 (01) : 1 - 21
  • [8] Atenolol gastrointestinal therapeutic system: Optimization of formulation variables using response surface methodology
    Sastry, SV
    Reddy, IK
    Khan, MA
    [J]. JOURNAL OF CONTROLLED RELEASE, 1997, 45 (02) : 121 - 130
  • [9] Stahl P.H., 2002, HDB PHARM SALTS PROP
  • [10] pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets
    Streubel, A
    Siepmann, J
    Dashevsky, A
    Bodmeier, R
    [J]. JOURNAL OF CONTROLLED RELEASE, 2000, 67 (01) : 101 - 110